XEN1101 For the Treatment of Major Depressive Disorder (H-49454)

Baylor College of Medicine is conducting a clinical trial in individuals between the ages of 18-65 to study the effect of XEN1101 investigational medication on brain measures of reward (e.g. fMRI with reward task) in patients suffering from Major Depressive Disorder (MDD). The study is sponsored by the National Institute of Mental Health (NIMH).

If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation will also be provided for time and travel.